vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and TRIMAS CORP (TRS). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $256.5M, roughly 1.1× TRIMAS CORP). TRIMAS CORP runs the higher net margin — 31.9% vs 0.7%, a 31.1% gap on every dollar of revenue. On growth, TRIMAS CORP posted the faster year-over-year revenue change (3.8% vs -16.5%). TRIMAS CORP produced more free cash flow last quarter ($36.8M vs $3.4M).
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
Trimas Corp is a diversified industrial manufacturing enterprise that designs, produces and distributes a wide portfolio of engineered products, including specialized fasteners, aerospace components, custom packaging solutions, and consumer & industrial hardware. It primarily serves aerospace, automotive, construction, consumer goods and industrial sectors, with core operations across North America and selected global markets.
HCM vs TRS — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $270.8M | $256.5M |
| Net Profit | $2.0M | $81.7M |
| Gross Margin | 37.7% | 12.8% |
| Operating Margin | -13.2% | 5.7% |
| Net Margin | 0.7% | 31.9% |
| Revenue YoY | -16.5% | 3.8% |
| Net Profit YoY | -83.6% | 236.9% |
| EPS (diluted) | $0.00 | $2.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $256.5M | ||
| Q4 25 | $270.8M | $-140.0M | ||
| Q3 25 | — | $269.3M | ||
| Q2 25 | $277.7M | $274.8M | ||
| Q1 25 | $324.5M | $241.7M | ||
| Q4 24 | — | $-66.2M | ||
| Q3 24 | — | $229.4M | ||
| Q2 24 | $305.7M | $240.5M |
| Q1 26 | — | $81.7M | ||
| Q4 25 | $2.0M | $81.7M | ||
| Q3 25 | — | $9.3M | ||
| Q2 25 | $455.0M | $16.7M | ||
| Q1 25 | $11.9M | $12.4M | ||
| Q4 24 | — | $5.6M | ||
| Q3 24 | — | $2.5M | ||
| Q2 24 | $25.8M | $10.9M |
| Q1 26 | — | 12.8% | ||
| Q4 25 | 37.7% | — | ||
| Q3 25 | — | 12.8% | ||
| Q2 25 | 0.1% | 13.8% | ||
| Q1 25 | 48.0% | 13.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 15.4% | ||
| Q2 24 | 41.1% | 14.4% |
| Q1 26 | — | 5.7% | ||
| Q4 25 | -13.2% | — | ||
| Q3 25 | — | 6.2% | ||
| Q2 25 | -1.3% | 9.9% | ||
| Q1 25 | -5.0% | 9.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.6% | ||
| Q2 24 | -9.0% | 7.4% |
| Q1 26 | — | 31.9% | ||
| Q4 25 | 0.7% | -58.4% | ||
| Q3 25 | — | 3.5% | ||
| Q2 25 | 163.8% | 6.1% | ||
| Q1 25 | 3.7% | 5.1% | ||
| Q4 24 | — | -8.5% | ||
| Q3 24 | — | 1.1% | ||
| Q2 24 | 8.4% | 4.5% |
| Q1 26 | — | $2.03 | ||
| Q4 25 | $0.00 | $2.01 | ||
| Q3 25 | — | $0.23 | ||
| Q2 25 | $0.52 | $0.41 | ||
| Q1 25 | $0.01 | $0.30 | ||
| Q4 24 | — | $0.14 | ||
| Q3 24 | — | $0.06 | ||
| Q2 24 | $0.03 | $0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $30.0M |
| Total DebtLower is stronger | $93.2M | — |
| Stockholders' EquityBook value | $1.2B | $705.6M |
| Total Assets | $1.8B | $1.5B |
| Debt / EquityLower = less leverage | 0.08× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $30.0M | ||
| Q4 25 | $1.4B | $30.0M | ||
| Q3 25 | — | $33.6M | ||
| Q2 25 | $1.4B | $30.3M | ||
| Q1 25 | $836.1M | $32.7M | ||
| Q4 24 | — | $23.1M | ||
| Q3 24 | — | $26.9M | ||
| Q2 24 | $802.5M | $35.0M |
| Q1 26 | — | — | ||
| Q4 25 | $93.2M | $469.2M | ||
| Q3 25 | — | $407.1M | ||
| Q2 25 | $93.4M | $424.5M | ||
| Q1 25 | $82.8M | $434.2M | ||
| Q4 24 | — | $398.1M | ||
| Q3 24 | — | $409.9M | ||
| Q2 24 | $82.1M | $427.4M |
| Q1 26 | — | $705.6M | ||
| Q4 25 | $1.2B | $705.6M | ||
| Q3 25 | — | $725.0M | ||
| Q2 25 | $1.2B | $715.3M | ||
| Q1 25 | $759.9M | $686.6M | ||
| Q4 24 | — | $667.3M | ||
| Q3 24 | — | $682.8M | ||
| Q2 24 | $740.1M | $675.9M |
| Q1 26 | — | $1.5B | ||
| Q4 25 | $1.8B | $1.5B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | $1.8B | $1.4B | ||
| Q1 25 | $1.3B | $1.4B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | $1.3B | $1.4B |
| Q1 26 | — | — | ||
| Q4 25 | 0.08× | 0.66× | ||
| Q3 25 | — | 0.56× | ||
| Q2 25 | 0.08× | 0.59× | ||
| Q1 25 | 0.11× | 0.63× | ||
| Q4 24 | — | 0.60× | ||
| Q3 24 | — | 0.60× | ||
| Q2 24 | 0.11× | 0.63× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $117.5M |
| Free Cash FlowOCF − Capex | $3.4M | $36.8M |
| FCF MarginFCF / Revenue | 1.2% | 14.4% |
| Capex IntensityCapex / Revenue | 1.8% | 18.9% |
| Cash ConversionOCF / Net Profit | 4.21× | 1.44× |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | $109.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $117.5M | ||
| Q4 25 | $8.2M | $41.5M | ||
| Q3 25 | — | $36.5M | ||
| Q2 25 | $-72.9M | $30.3M | ||
| Q1 25 | $40.3M | $9.2M | ||
| Q4 24 | — | $27.1M | ||
| Q3 24 | — | $22.0M | ||
| Q2 24 | $-39.8M | $18.4M |
| Q1 26 | — | $36.8M | ||
| Q4 25 | $3.4M | $36.8M | ||
| Q3 25 | — | $22.8M | ||
| Q2 25 | $-82.2M | $13.2M | ||
| Q1 25 | $32.5M | $-3.8M | ||
| Q4 24 | — | $12.1M | ||
| Q3 24 | — | $10.2M | ||
| Q2 24 | $-49.9M | $7.5M |
| Q1 26 | — | 14.4% | ||
| Q4 25 | 1.2% | -26.3% | ||
| Q3 25 | — | 8.5% | ||
| Q2 25 | -29.6% | 4.8% | ||
| Q1 25 | 10.0% | -1.6% | ||
| Q4 24 | — | -18.3% | ||
| Q3 24 | — | 4.4% | ||
| Q2 24 | -16.3% | 3.1% |
| Q1 26 | — | 18.9% | ||
| Q4 25 | 1.8% | -3.4% | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | 3.3% | 6.2% | ||
| Q1 25 | 2.4% | 5.4% | ||
| Q4 24 | — | -22.6% | ||
| Q3 24 | — | 5.2% | ||
| Q2 24 | 3.3% | 4.5% |
| Q1 26 | — | 1.44× | ||
| Q4 25 | 4.21× | 0.51× | ||
| Q3 25 | — | 3.92× | ||
| Q2 25 | -0.16× | 1.81× | ||
| Q1 25 | 3.38× | 0.74× | ||
| Q4 24 | — | 4.80× | ||
| Q3 24 | — | 8.71× | ||
| Q2 24 | -1.54× | 1.68× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
